Global Defibrillator Market Trends, Analysis, Growth, and Forecast: 2018 to 2027

MarketResearch.biz delivers in-depth insights on the global defibrillator market in its upcoming report titled, “Global Defibrillator Market Trends, Applications, Analysis, Growth, and Forecast: 2018 to 2027”. The global defibrillator market is estimated to register a CAGR of X.X% in terms of value during forecast period 2018–2027. The report offers in-depth insights, revenue details, and other vital information regarding the target market, and the various trends, drivers, restraints, opportunities, and threats till 2027. The report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global defibrillator market report has been segmented on the basis of product type, end user, and region.

Request Covid - 19 Impact

Defibrillator is a device that delivers high electric shocks, the procedure is used to treat life threatening conditions such as ventricular fibrillation, pulseless ventricular tachycardia, and cardiac arrhythmia. There are different types of defibrillators available in market such as implanted defibrillators and external defibrillators. Defibrillators are easy to use, portable, fully automated and user friendly. Defibrillators are available in public places and hence it is also known as public access defibrillators. It helps in increasing the survival rate from sudden cardiac arrest. Defibrillator provides number of benefits such as continuous monitoring of heart rhythms, provides protection and acts as a lifesaving therapy.

Increasing incidence of cardiovascular diseases globally is expected to fuel the growth of global defibrillator market over the forecast period. Moreover, growing geriatric population coupled with risk of getting cardiac diseases is expected to contribute to the market growth. Furthermore, technological advancements and innovation in defibrillator and increasing awareness regarding use of device is expected to drive the global defibrillator market over the forecast period.

However, manufacturers can develop defibrillators which can minimize the risk of infection, allergic reaction and vein damage which is expected to create new opportunities for existing as well as new market entrant in the global defibrillator market over the forecast period.

North America market dominates the global defibrillator market in terms of revenue contribution as compared to that of markets in other regions. This is attributed to the presence of well-developed healthcare infrastructure and favorable reimbursement schemes in the region. Europe accounts for second-largest revenue share contribution to the global defibrillator market, followed by markets in the Asia Pacific, Latin America, and the Middle East & Africa respectively. The market in the Europe is projected to register comparatively faster growth in terms of revenue over the next 10 years owing increasing incidence of cardiovascular diseases and increasing awareness of defibrillator in the region.

Global defibrillator market segmentation, by product type:

• Implantable Cardioverter Defibrillators
  • Transvenous Implantable Cardioverter Defibrillators
    • Single Chamber
    • Dual Chamber
    • Cardiac Resynchronization Therapy Defibrillators (CRT-D)
  • Subcutaneous Implantable Cardioverter Defibrillators (S-ICDS)
• External Defibrillator
  • Automated External Defibrillators (AEDS)
  • Manual External Defibrillators
  • Wearable Cardioverter Defibrillators (WCDS)

Global defibrillator market segmentation, by end user:

• Hospital
• Prehospital
• Public Access Market
• Alternate Care Market
• Home Healthcare

Global defibrillator market segmentation, by region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

• Medtronic Plc.
• Boston Scientific Corporation
• LivaNova Plc.
• Koninklijke Philips N.V.
• Zoll Medical Corporation
• Defibtech, LLC.
• Biotronik SE & Co. KG
• Schiller AG
• HeartSine Technologies, LLC.
• Physio-Control, Inc.